Comprehensive genomic profiling (CGP) is advancing precision oncology through the analysis of multiple relevant biomarkers in a single next-generation sequencing (NGS) test. From a single analysis of a small sample, one can gather comprehensive genomic information to drive optimal patient treatment and care.

The Oncomine Comprehensive Plus (OncoPlus) assay profiles more than 500 unique genes allowing for the detection of multiple predictive and prognostic biomarkers in one test.

Oncomine Comprehensive Plis (OncoPllus) NGS for Solid Tumours